Provence Wealth Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Provence Wealth Management Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.04K	Hold	34	–	–	﹤0.01%	385
2023 Q3	$2.48K	Buy	+34	New	+$2.72K	﹤0.01%	393

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

Provence Wealth Management Group's XBI Position: Q4 2023 in Review

Provence Wealth Management Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2023 at 34 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

Provence Wealth Management Group first reported a position in XBI in Q3 2023 and has held it in 2 quarters since. 746 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Provence Wealth Management Group held 34 shares of State Street SPDR S&P Biotech ETF worth $3.04K as of Q4 2023.
Provence Wealth Management Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2023.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Provence Wealth Management Group's portfolio in Q4 2023, its #385 holding.
Provence Wealth Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 2 quarters since.
746 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.